Interleukin-12 is produced by macrophages in response to live or killed Bordetella pertussis and enhances the efficacy of an acellular pertussis vaccine by promoting induction of Th1 cells
about
Mesenchymal stem cells avoid allogeneic rejectionEfficient delivery of small interfering RNA for inhibition of IL-12p40 expression in vivoPertussis: Microbiology, Disease, Treatment, and Prevention.Combination of pneumococcal surface protein A (PspA) with whole cell pertussis vaccine increases protection against pneumococcal challenge in miceAcellular pertussis vaccine protects against exacerbation of allergic asthma due to Bordetella pertussis in a murine model.A murine model in which protection correlates with pertussis vaccine efficacy in children reveals complementary roles for humoral and cell-mediated immunity in protection against Bordetella pertussis.Interleukin-12 has a role in mediating resistance of murine strains to Tyzzer's disease.Protective effects of pertussis immunoglobulin (P-IGIV) in the aerosol challenge modelMutants of Escherichia coli heat-labile toxin act as effective mucosal adjuvants for nasal delivery of an acellular pertussis vaccine: differential effects of the nontoxic AB complex and enzyme activity on Th1 and Th2 cells.A regulatory role for interleukin 4 in differential inflammatory responses in the lung following infection of mice primed with Th1- or Th2-inducing pertussis vaccines.Long-term pertussis-specific immunity after primary vaccination with a combined diphtheria, tetanus, tricomponent acellular pertussis, and hepatitis B vaccine in comparison with that after natural infection.Immunogenicity and protective efficacy of neonatal vaccination against Bordetella pertussis in a murine model: evidence for early control of pertussis.Quantitative priming with inactivated pertussis toxoid vaccine in the aerosol challenge model.c-di-GMP enhances protective innate immunity in a murine model of pertussisIn vivo efficacy of a chitosan/IL-12 adjuvant system for protein-based vaccinesA live, attenuated Bordetella pertussis vaccine provides long-term protection against virulent challenge in a murine model.T-cell immune response assessment as a complement to serology and intranasal protection assays in determining the protective immunity induced by acellular pertussis vaccines in mice.Effect of different forms of adenylate cyclase toxin of Bordetella pertussis on protection afforded by an acellular pertussis vaccine in a murine model.Vaccine- and antigen-dependent type 1 and type 2 cytokine induction after primary vaccination of infants with whole-cell or acellular pertussis vaccines.Intracellular Salmonella dublin induces substantial secretion of the 40-kilodalton subunit of interleukin-12 (IL-12) but minimal secretion of IL-12 as a 70-kilodalton protein in murine macrophages.Phase variation affects long-term survival of Bordetella bronchiseptica in professional phagocytes.Regression of Peyer's patches in G alpha i2 deficient mice prior to colitis is associated with reduced expression of Bcl-2 and increased apoptosis.Atypical disease after Bordetella pertussis respiratory infection of mice with targeted disruptions of interferon-gamma receptor or immunoglobulin mu chain genesPrimary role for Gi protein signaling in the regulation of interleukin 12 production and the induction of T helper cell type 1 responses.Decreased leukocyte accumulation and delayed Bordetella pertussis clearance in IL-6-/- miceImmunogenicity of a whole-cell pertussis vaccine with low lipopolysaccharide content in infants.IL-10 induction by Bordetella parapertussis limits a protective IFN-gamma response.Phagosome acidification has opposite effects on intracellular survival of Bordetella pertussis and B. bronchiseptica.Antigen-specific responses to diphtheria-tetanus-acellular pertussis vaccine in human infants are initially Th2 polarized.Production of interleukin-12 by murine macrophages in response to bacterial peptidoglycan.Interleukin-12 in infectious diseases.Protective Role of Passively Transferred Maternal Cytokines against Bordetella pertussis Infection in Newborn Piglets.Intracellular trafficking of Bordetella pertussis in human macrophages.Bordetella pertussis-infected human monocyte-derived dendritic cells undergo maturation and induce Th1 polarization and interleukin-23 expression.Booster immunization of children with an acellular pertussis vaccine enhances Th2 cytokine production and serum IgE responses against pertussis toxin but not against common allergens.Inhibition of murine allergic airway disease by Bordetella pertussis.T cell responses to vaccines in infants: defective IFNgamma production after oral polio vaccination.
P2860
Q21245658-A45DE062-DC01-42B6-9256-E3801E41D56DQ24806391-AA626074-9094-4A91-B876-FB8DE0D5F9BEQ30251684-4D44BCFB-47EF-4A21-81B7-8120559A0132Q33594345-23695F80-1BC1-4A48-8DB4-09EA33EFD0D1Q33716587-8F7164B8-11A1-406D-B76A-2E67758BB7AAQ33750257-1D505201-E445-4B39-8D52-D10E3459FA98Q33766377-E64F9003-BFBD-4712-B92D-77FDA4D50DFCQ33866775-B174A984-9F38-43C8-A416-0BC6CC3E5BFDQ34002672-1EA7E750-437F-44E0-9117-51E9D2EE273DQ34003563-6D9D64ED-A8F8-4715-8094-3DDB14761697Q34008317-B5AD4C72-7CD7-440A-88ED-5155819FC8CCQ34126969-B0CB38CF-D752-4B63-9EE0-F51005A75094Q34129001-662151C9-072F-4778-AF9B-95ECD325F780Q34343647-C84C557A-986D-4B47-8ED4-68D621DA2AD7Q34356322-41C08764-E9DD-4CD9-BBF6-D0BF9143501CQ34738678-5EC29189-8640-4A3B-9E6D-B0445BE1472CQ35140321-D0E53158-FB73-409E-9D06-7AD02EC2F819Q35220336-C9735D09-5C7F-45C8-B706-7728157D0007Q35548872-8889B931-111F-4C33-9A84-1A4F48D01DF6Q35552545-5D65328A-BAA7-45E5-909D-69D924F3079FQ35553903-30F8784D-C6F8-4AD2-9121-C7B1D595C52EQ35594988-75903311-1B21-46DA-AC76-5A5D5E9948C8Q36380922-16FD02A8-2035-4680-8F28-8BCC95CCC519Q36404327-D99F55BC-4D93-4694-A584-130100BFA7BEQ36746359-0007B0C1-3680-4DB5-8E40-31C1654C4AE6Q37156751-8F923580-DD9A-4BCD-B592-5BC4759EADA9Q37529638-B35D38E4-DC79-4979-99B3-1EAAD89F1B7BQ39517446-B48E34DD-8889-4A80-9AA9-4D124C5ADDF4Q39537512-CBADD3D5-3D56-4B89-BAC8-FCA570E9DAEAQ39573301-CE9E2CDC-1752-4625-BEF6-C722B88D8EE5Q39820841-072ACC7A-C361-4F7C-B04F-71BE22156CFCQ40342590-B385AEEC-2278-4991-B681-4A70F52F5A7AQ41880823-703899FB-4DFD-4209-B7BE-23424B757E71Q42125528-5EB08A50-33CC-4DD0-9C40-EB8F80ABE45DQ44125693-CDAA1282-3F6E-42CF-8DE8-6DD15A4D48A1Q44990764-C951D2DD-4118-48DE-9AEA-3914A795BD2BQ52938988-49EAFEB0-059D-4D50-BF2D-C6E1F224D4EF
P2860
Interleukin-12 is produced by macrophages in response to live or killed Bordetella pertussis and enhances the efficacy of an acellular pertussis vaccine by promoting induction of Th1 cells
description
1996 nî lūn-bûn
@nan
1996 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
1996 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
1996年の論文
@ja
1996年論文
@yue
1996年論文
@zh-hant
1996年論文
@zh-hk
1996年論文
@zh-mo
1996年論文
@zh-tw
1996年论文
@wuu
name
Interleukin-12 is produced by ...... omoting induction of Th1 cells
@ast
Interleukin-12 is produced by ...... omoting induction of Th1 cells
@en
type
label
Interleukin-12 is produced by ...... omoting induction of Th1 cells
@ast
Interleukin-12 is produced by ...... omoting induction of Th1 cells
@en
prefLabel
Interleukin-12 is produced by ...... omoting induction of Th1 cells
@ast
Interleukin-12 is produced by ...... omoting induction of Th1 cells
@en
P2093
P2860
P1476
Interleukin-12 is produced by ...... omoting induction of Th1 cells
@en
P2093
P2860
P304
P407
P577
1996-12-01T00:00:00Z